Advertisement

Latest Articles in pharma

Biocon Pulls Application For EU Approval Of Two Drugs

Biocon will re-submit the applications for breast cancer drug Trastuzumab and Pegfilgrastim, which cuts infection risk in patients undergoing chemotherapy, after the European Medicines Agency completes the inspection

Read More

Pharma@70: Drug Makers Seek Freedom From Dependence On Chinese Imports And Unforeseen Regulatory Changes

No lapses can be greater than the loop holes in the country’s medicine making and distribution market

Read More

India Raises Concerns Around Chinese Firm Fosun's Takeover Of Gland

The deal has won the approval of the Competition Commission of India (CCI) and India's Foreign Investment Promotion Board (FIPB) in the last few months, but some in the government have expressed concerns

Read More

Torrent Pharma Revenue Drops 11% To Rs 1374

Profit After Tax for Q1 2017-18 was seen decreasing at Rs 188 crore as against Rs 292 crore during the same period last year

Read More

On The Offensive

The future lies in innovation and building businesses in chosen therapeutic categories

Read More

In The Spotlight For New Reasons

Several Indian pharma companies and CROs were issued warning letters last year for fudging data

Read More

Finding New Markets To Grow

India’s pharma exports are shrinking. Focusing on smaller, emerging markets can reverse the trend

Read More

Lupin Sets Off Down Indian Pharma's Long Road To Redemption

More than 40 plants have been banned by the FDA for issues ranging from data fraud to hygiene since India's then-largest drugmaker Ranbaxy was pulled up for serious violations in 2008

Read More

Glenmark Acquires Development, Commercial Rights For Novel Cancer Molecule From US Firm

Glenmark Pharmaceuticals entered into a licensing agreement with the Boston-based APC Therapeutics Inc, a biopharmaceutical research firm focused on building a portfolio of immuno-oncology therapies, acquiring rights of a potential cancer drug molecule that is currently under development

Read More

Millions Of Employees In Healthcare Sector Are At Risk Of Losing Jobs

With price control over cardiac stents and generic prescription proposal, medical device makers and pharmaceutical giants are expected to hand over pink slips to their employees

Read More

Goverment Extends Price Control Over Commonly Used Vaccinations And Medicines

Drug price watchdog, National Pharmaceutical Pricing Authority (NPPA) has fixed or revised retail prices of 37 scheduled formulations

Read More

Dr Reddy's Sees No Impact From Pricing Regulator Notice

Dr Reddy's Laboratories Ltd, India's second-largest drugmaker by sales, said it expects no impact from a recent government notice that said the company is selling a high blood pressure drug that lacks the pricing regulator's approval.

Read More

Merck Opens New M Lab Collaboration Centre In Bengaluru

The new M Lab Collaboration Centre in Bengaluru is one of the company’s 9 such centers around the world

Read More